MDP.TO
Medexus Pharmaceuticals Inc
Price:  
2.55 
CAD
Volume:  
21,000.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDP.TO WACC - Weighted Average Cost of Capital

The WACC of Medexus Pharmaceuticals Inc (MDP.TO) is 8.1%.

The Cost of Equity of Medexus Pharmaceuticals Inc (MDP.TO) is 10.15%.
The Cost of Debt of Medexus Pharmaceuticals Inc (MDP.TO) is 6.45%.

Range Selected
Cost of equity 8.50% - 11.80% 10.15%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.40% - 7.50% 6.45%
WACC 6.8% - 9.4% 8.1%
WACC

MDP.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 1.04 1.25
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.50% 11.80%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.61 0.61
Cost of debt 5.40% 7.50%
After-tax WACC 6.8% 9.4%
Selected WACC 8.1%